Chemours
487 hedge funds and large institutions have $3.23B invested in Chemours in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 116 increasing their positions, 176 reducing their positions, and 48 closing their positions.
44% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 48
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
3% more funds holding
Funds holding: 474 → 487 (+13)
0.9% more ownership
Funds ownership: 71.62% → 72.52% (+0.9%)
0% less capital invested
Capital invested by funds: $3.24B → $3.23B (-$12.2M)
6% less call options, than puts
Call options by funds: $47.1M | Put options by funds: $50M
34% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 176
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$113M |
| 2 |
Millennium Management
New York
|
+$20.6M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
+$15.2M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$10.9M |
| 5 |
HF
HRT Financial
New York
|
+$9.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$28.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.5M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$25.1M |
| 4 |
Legal & General Group
London,
United Kingdom
|
-$23.1M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$15.6M |
CC Hedge Fund Activity: Q1 2023 in Review
487 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2023, worth a combined $3.23B — down 0.38% from $3.24B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new CC positions and 48 closed out — a net gain of 21 holders — while 116 added to existing stakes and 176 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $113M. The largest seller was BlackRock, cutting an estimated $28.9M.
- 487 institutional investors held Chemours (CC) as of Q1 2023, up from 474 in Q4 2022.
- Funds reported $3.23B of Chemours stock for Q1 2023, down 0.38% quarter-over-quarter.
- 69 funds opened new Chemours positions in Q1 2023 and 48 closed out, a net change of +21 holders.
- The largest Chemours buyer in Q1 2023 was Fidelity Investments, an estimated $113M added.
- The largest Chemours seller in Q1 2023 was BlackRock, an estimated $28.9M sold.
Based on aggregated 13F filings for Q1 2023.